Intravenous versus subcutaneous drug administration. Which do patients prefer? A systematic review

Stoner, Kelly L, Harder, Helena, Fallowfield, Lesley J and Jenkins, Valerie A (2015) Intravenous versus subcutaneous drug administration. Which do patients prefer? A systematic review. The Patient, 8 (2). pp. 145-153. ISSN 1178-1653

[img]
Preview
PDF - Accepted Version
Download (425kB) | Preview

Abstract

BACKGROUND:

Intravenous (IV) drug delivery is commonly used for its rapid administration and immediate drug effect. Most studies compare IV to subcutaneous (SC) delivery in terms of safety and efficacy, but little is known about what patients prefer.

METHODS:

A systematic review was conducted by searching seven electronic databases for articles published up to February 2014. Included studies were randomized controlled trials (RCTs) and/or crossover designs investigating patient preference for SC versus IV administration. The risk of bias in the RCTs was determined using the Cochrane Collaboration tool. Reviewers independently extracted data and assessed the risk of bias. Any discrepancies were resolved by consensus.

RESULTS:

The search identified 115 publications, but few (6/115) met the inclusion criteria. Patient populations and drugs investigated were diverse. Four of six studies demonstrated a clear patient preference for SC administration. Main factors associated with SC preference were time saving and the ability to have treatment at home. Only three studies used study-specific instruments to measure preference.

CONCLUSIONS:

Results suggest that patients prefer SC over IV delivery. Patient preference has clearly been neglected in clinical research, but it is important in medical decision making when choosing treatment methods as it has implications for adherence and quality of life. If the safety and efficacy of both administration routes are equivalent, then the most important factor should be patient preference as this will ensure optimal treatment adherence and ultimately improve patient experience or satisfaction. Future drug efficacy and safety studies should include contemporaneous, actual patient preference where possible, utilizing appropriate measures.

Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Sussex Health Outcomes Research & Education in Cancer (SHORE-C)
Subjects: R Medicine
Depositing User: Kathryn Monson
Date Deposited: 06 Aug 2014 15:36
Last Modified: 07 Mar 2017 06:20
URI: http://sro.sussex.ac.uk/id/eprint/49501

View download statistics for this item

📧 Request an update